Page 10 - Nt Ears News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data from a prospective study support the use of parathyroid hormone (PTH) to guide earlier discharge of patients after surgery.

With the neoadjuvant regimen of pembrolizumab added to dabrafenib and trametinib, survival in BRAF-mutated forms of the highly aggressive cancer can go from months to more than 5 years.

The safety and tolerability of etripamil, an investigational nasal spray for paroxysmal supraventricular tachycardia (PSVT), are maintained in new data from the NODE-302 extension study.

Patients with nonerosive GERD do not have a greater risk for esophageal cancer compared with the general population and are unlikely to need additional endoscopic monitoring for cancer.

The FDA is cracking down on lax testing practices by dozens of makers of healthcare products following hundreds of deaths overseas from contaminated cough syrups.